Neuroendocrine tumor of the breast - metastasis or primary breast carcinoma? Case report

Česká verzia

Authors: Markéta Petrová
Authors place of work: Oddělení patologické anatomie, Oblastní nemocnice Náchod a. s.
Published in the journal: Čes.-slov. Patol., 51, 2015, No. 3, p. 128-131
Category: Původní práce

Summary

A 74-year-old women with a history of neuroendocrine tumor in the terminal ileum presented on screening mammography with an irregular hypoechogenic mass in the upper outer quadrant of the left breast. A core biopsy showed a neuroendocrine tumor, interpreted as a probable metastasis from the intestinal primary. Other masses were found in the right lobe of the liver. Resection of the masses in the breast and liver was performed at the same time. Morphological and immunohistochemical findings (positive neuroendocrine markers, estrogene receptors and negative cytokeratine 7, mammaglobin, GCDFP-15, cytokeratine 20 and progesterone receptors) were consistent with a diagnosis of a metastatic well-differentiated neuroendocrine tumor, despite some estrogen receptor positivity. Issues of primary and metastatic breast neuroendocrine tumors are discussed in detail.

Keywords:
neuroendocrine tumor – breast carcinoma – metastasis

Zdroje

1. Ogawa H, Nishio A, Satake H, et al. Neuroendocrine tumor in the breast. Radiat Med 2008; 26(1): 28–32.

2. Kinkor Z, Mečiarová I. Metastázy epitelových neuroendokrinních tumorů do prsu – omyl není nutný. Breast Cancer News 2013; 3(2): 4-7.

3. Vizcaino I, Torregrosa A, Higueras V, et al. Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature. Eur Radiol 2001; 11(9): 1659-1665.

4. Srirajaskanthan R, Desai K, Jayaratnam A, Carras E, Toumpanakis C, Meyer T, Caplin M. Uncommon sites for metastasis of neuroendocrine tumor in adults. J Clin Oncol 2009; 27(15S): e15683.

5. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumours of the Breast (4th ed.).Lyon: IARC; 2012: 62-63.

6. Hanby AM, Brannan R. Neuroendocrine Tumours of the Breast. In: Khan A. Surgical Pathology of Endocrine and Neuroendocrine Tumours. New York, NY: Humana Press; 2009: 165-172.

7. Akhtar K, Zaheer S, Ahmad SS, Hassan MJ. Primary neuroendocrine carcinoma of the breast. Indian J Pathol Microbiol 2009; 52(1): 71–73.

8. Tavassoli FA, Devilee P. WHO Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC; 2003: 32-34.

9. Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 2000; 17(2): 127–37.

10. Fritzsche FR, Thomas A, Winzer KJ, et al. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol 2007; 22(11): 1221-1230.

11. Ghanem S, Kabaj H, Naciri S, Glaoui M, Ismaili N, Benjaafar N, Errihani H. Primary neuroendocrine carcinoma of the breast: A rare and distinct entity. J Canc Res Exp Oncol 2011; 3(5): 50-54.

12. Richter-Ehrenstein CH, Arndt J, Buchendahl ACH, et al. Solid neuroendocrine carcinoma of the breast. Metastases or primary tumors? Breast Canc Res Treat 2010; 124(2): 413-417.

13. Crona J, Granberg D, Norlen O, Wärnberg F, Stålberg P, Hellman P, Björklund P. Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall? World J Surg 2013; 37(7): 1701-6.

14. Sica G, Wagner PL, Altorki N et al. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med 2008; 132(12): 1889–1895.

15. Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol 2007; 15(4): 407-414.

16. O’Connell FP, Wang HH, Odze RD. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005; 129(3): 338-347.